FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896779918> ?p ?o ?g. }

• W2896779918 abstract "The collective cognitive and motor deficits known as HIV-associated neurocognitive disorders (HAND) remain high even among HIV+ individuals whose antiretroviral therapy is optimized. HAND is worsened in the context of opiate abuse. The mechanism of exacerbation remains unclear but likely involves chronic immune activation of glial cells resulting from persistent, low-level exposure to the virus and viral proteins. We tested whether signaling through C-C chemokine receptor type 5 (CCR5) contributes to neurotoxic interactions between HIV-1 transactivator of transcription (Tat) and opiates and explored potential mechanisms. Neuronal survival was tracked in neuronal and glial co-cultures over 72 h of treatment with HIV-1 Tat ± morphine using cells from CCR5-deficient and wild-type mice exposed to the CCR5 antagonist maraviroc or exogenously-added BDNF (analyzed by repeated measures ANOVA). Intracellular calcium changes in response to Tat ± morphine ± maraviroc were assessed by ratiometric Fura-2 imaging (analyzed by repeated measures ANOVA). Release of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF from CCR5-deficient and wild-type glia was measured by ELISA (analyzed by two-way ANOVA). Levels of CCR5 and μ-opioid receptor (MOR) were measured by immunoblotting (analyzed by Student’s t test). HIV-1 Tat induces neurotoxicity, which is greatly exacerbated by morphine in wild-type cultures expressing CCR5. Loss of CCR5 from glia (but not neurons) eliminated neurotoxicity due to Tat and morphine interactions. Unexpectedly, when CCR5 was lost from glia, morphine appeared to entirely protect neurons from Tat-induced toxicity. Maraviroc pre-treatment similarly eliminated neurotoxicity and attenuated neuronal increases in [Ca2+]i caused by Tat ± morphine. proBDNF/BDNF ratios were increased in conditioned media from Tat ± morphine-treated wild-type glia compared to CCR5-deficient glia. Exogenous BDNF treatments mimicked the pro-survival effect of glial CCR5 deficiency against Tat ± morphine. Our results suggest a critical role for glial CCR5 in mediating neurotoxic effects of HIV-1 Tat and morphine interactions on neurons. A shift in the proBDNF/BDNF ratio that favors neurotrophic support may occur when glial CCR5 signaling is blocked. Some neuroprotection occurred only in the presence of morphine, suggesting that loss of CCR5 may fundamentally change signaling through the MOR in glia." @default.
• W2896779918 created "2018-10-26" @default.
• W2896779918 creator A5019195399 @default.
• W2896779918 creator A5027249949 @default.
• W2896779918 creator A5048863722 @default.
• W2896779918 creator A5057352924 @default.
• W2896779918 creator A5061374409 @default.
• W2896779918 creator A5071798627 @default.
• W2896779918 creator A5076458805 @default.
• W2896779918 date "2018-10-10" @default.
• W2896779918 modified "2023-10-16" @default.
• W2896779918 title "A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates" @default.
• W2896779918 cites W141636555 @default.
• W2896779918 cites W1496715908 @default.
• W2896779918 cites W1517417834 @default.
• W2896779918 cites W1530364137 @default.
• W2896779918 cites W1546717961 @default.
• W2896779918 cites W1600123087 @default.
• W2896779918 cites W1849091229 @default.
• W2896779918 cites W1974899939 @default.
• W2896779918 cites W1976915575 @default.
• W2896779918 cites W1977175874 @default.
• W2896779918 cites W1981644527 @default.
• W2896779918 cites W1990773400 @default.
• W2896779918 cites W1991556620 @default.
• W2896779918 cites W1993264471 @default.
• W2896779918 cites W1994597727 @default.
• W2896779918 cites W1995215826 @default.
• W2896779918 cites W1996476108 @default.
• W2896779918 cites W1998529637 @default.
• W2896779918 cites W2000250827 @default.
• W2896779918 cites W2003186832 @default.
• W2896779918 cites W2007021820 @default.
• W2896779918 cites W2008684344 @default.
• W2896779918 cites W2010358244 @default.
• W2896779918 cites W2014363182 @default.
• W2896779918 cites W2014439767 @default.
• W2896779918 cites W2015983043 @default.
• W2896779918 cites W2017486089 @default.
• W2896779918 cites W2019683276 @default.
• W2896779918 cites W2021151285 @default.
• W2896779918 cites W2026455599 @default.
• W2896779918 cites W2029843028 @default.
• W2896779918 cites W2031386216 @default.
• W2896779918 cites W2039683993 @default.
• W2896779918 cites W2043523440 @default.
• W2896779918 cites W2045301606 @default.
• W2896779918 cites W2045934707 @default.
• W2896779918 cites W2046630371 @default.
• W2896779918 cites W2052151114 @default.
• W2896779918 cites W2052769426 @default.
• W2896779918 cites W2061438637 @default.
• W2896779918 cites W2064345416 @default.
• W2896779918 cites W2067356106 @default.
• W2896779918 cites W2069008547 @default.
• W2896779918 cites W2069964596 @default.
• W2896779918 cites W2077702812 @default.
• W2896779918 cites W2078030437 @default.
• W2896779918 cites W2083519153 @default.
• W2896779918 cites W2086990722 @default.
• W2896779918 cites W2087579640 @default.
• W2896779918 cites W2087919519 @default.
• W2896779918 cites W2091188145 @default.
• W2896779918 cites W2094917057 @default.
• W2896779918 cites W2095083924 @default.
• W2896779918 cites W2096500024 @default.
• W2896779918 cites W2101925441 @default.
• W2896779918 cites W2103348038 @default.
• W2896779918 cites W2104741590 @default.
• W2896779918 cites W2113466274 @default.
• W2896779918 cites W2114601677 @default.
• W2896779918 cites W2115118763 @default.
• W2896779918 cites W2122906925 @default.
• W2896779918 cites W2126787868 @default.
• W2896779918 cites W2131731344 @default.
• W2896779918 cites W2137321682 @default.
• W2896779918 cites W2138411110 @default.
• W2896779918 cites W2142529927 @default.
• W2896779918 cites W2149410369 @default.
• W2896779918 cites W2150886578 @default.
• W2896779918 cites W2157355643 @default.
• W2896779918 cites W2161126635 @default.
• W2896779918 cites W2161976500 @default.
• W2896779918 cites W2165510333 @default.
• W2896779918 cites W2167145970 @default.
• W2896779918 cites W2253819451 @default.
• W2896779918 cites W2296001174 @default.
• W2896779918 cites W2416732024 @default.
• W2896779918 cites W2424874132 @default.
• W2896779918 cites W2516515961 @default.
• W2896779918 cites W2525939086 @default.
• W2896779918 cites W2608642538 @default.
• W2896779918 cites W2742622190 @default.
• W2896779918 cites W2769995987 @default.
• W2896779918 cites W2778890425 @default.
• W2896779918 cites W309039557 @default.
• W2896779918 cites W4313371726 @default.
• W2896779918 cites W87068116 @default.
• W2896779918 doi "https://doi.org/10.1186/s12974-018-1320-4" @default.
• W2896779918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6180355" @default.

• next